
zzso is a new zzso zzso zzso that has demonstrated good zzso and interesting activity in a large spectrum of solid zzso It was the aim of this paper to report the presence of a rarely documented side zzso 

In our experience, 135 patients were treated with zzso during the period zzso to zzso for a total of zzso zzso In zzso of the cycles, zzso was administered in zzso and in zzso in zzso zzso The dose of zzso administered in a weekly schedule, was 25 zzso in 109 patients and 30 zzso in 26 zzso In general, no zzso zzso was zzso zzso patients had lung cancer, 45 had breast cancer, and 25 zzso zzso Only 4 patients had a previous history of zzso 

Ten patients zzso had pain in the tumor site within a few minutes of the zzso zzso According to WHO grade, 5 cases had moderate and 5 severe zzso zzso was always zzso In 5 cases zzso was administered after pain detection with resolution of the zzso in 4 cases it was necessary to deliver zzso One patient was admitted to the coronary unit because a zzso zzso was suspected after zzso pain and required zzso zzso Seven cases refused to continue the treatment, and 3 cases had no further problem after zzso zzso 

Although rare, the presence of severe pain after zzso injection may adversely affect the treatment zzso Such data are helpful in the recognition and management of this zzso side zzso 

